About Sarcomatrix
Sarcomatrix is a company based in Reno (United States) founded in 2013. It operates as a B2B. Sarcomatrix offers products and services including S969 and LAM 111. Sarcomatrix operates in a competitive market with competitors including Juvena Therapeutics, Expansion Therapeutics, Vita Therapeutics, Amplicore and ML Bio Solutions, among others.
- Headquarter Reno, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Sarcomatrix Therapeutics Corp
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sarcomatrix
Sarcomatrix offers a comprehensive portfolio of products and services, including S969 and LAM 111. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Small molecule activator for muscular dystrophy treatment.
Protein for use in gene therapies for muscle diseases.
Funding Insights of Sarcomatrix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Sarcomatrix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sarcomatrix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sarcomatrix Comparisons
Competitors of Sarcomatrix
Sarcomatrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Juvena Therapeutics, Expansion Therapeutics, Vita Therapeutics, Amplicore and ML Bio Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based therapies for sarcopenia and muscle regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Software for RNA-based drug development is provided by the company.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for muscular dystrophies are developed using iPSC technology.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for musculoskeletal diseases are provided.
|
|
| domain | founded_year | HQ Location |
Develops novel oral therapies for rare genetic muscle disorders through research partnerships.
|
|
| domain | founded_year | HQ Location |
Antisense oligonucleotide therapies for rare genetic disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Sarcomatrix
When was Sarcomatrix founded?
Sarcomatrix was founded in 2013.
Where is Sarcomatrix located?
Sarcomatrix is headquartered in Reno, United States. It is registered at Reno, Nevada, United States.
What does Sarcomatrix do?
Sarcomatrix is a biotechnology company based in Reno, Nevada, USA, that focuses on creating treatments for muscle wasting diseases like muscular dystrophies, cachexia, and sarcopenia. They leverage scientific advancements in muscle regeneration and extracellular matrix interactions to develop therapies such as S969 and LAM 111. The company collaborates with patient advocacy groups and seeks investments to accelerate drug development and clinical trials.
Who are the top competitors of Sarcomatrix?
Sarcomatrix's top competitors include Juvena Therapeutics, Vita Therapeutics and Expansion Therapeutics.
What products or services does Sarcomatrix offer?
Sarcomatrix offers S969 and LAM 111.